291 related articles for article (PubMed ID: 33428284)
21. Impact of a pharmacist-led substance use disorder transitions of care clinic on postdischarge medication treatment retention.
Smith A; Hansen J; Colvard M
J Subst Abuse Treat; 2021 Nov; 130():108440. PubMed ID: 34118708
[TBL] [Abstract][Full Text] [Related]
22. Perceptions, policies, and practices related to dispensing buprenorphine for opioid use disorder: A national survey of community-based pharmacists.
Hill LG; Light AE; Green TC; Burns AL; Sanaty Zadeh P; Freeman PR
J Am Pharm Assoc (2003); 2023; 63(1):252-260.e6. PubMed ID: 36202711
[TBL] [Abstract][Full Text] [Related]
23. PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment.
Campbell CI; Saxon AJ; Boudreau DM; Wartko PD; Bobb JF; Lee AK; Matthews AG; McCormack J; Liu DS; Addis M; Altschuler A; Samet JH; LaBelle CT; Arnsten J; Caldeiro RM; Borst DT; Stotts AL; Braciszewski JM; Szapocznik J; Bart G; Schwartz RP; McNeely J; Liebschutz JM; Tsui JI; Merrill JO; Glass JE; Lapham GT; Murphy SM; Weinstein ZM; Yarborough BJH; Bradley KA
Addict Sci Clin Pract; 2021 Jan; 16(1):9. PubMed ID: 33517894
[TBL] [Abstract][Full Text] [Related]
24. Geographic Distribution of Providers With a DEA Waiver to Prescribe Buprenorphine for the Treatment of Opioid Use Disorder: A 5-Year Update.
Andrilla CHA; Moore TE; Patterson DG; Larson EH
J Rural Health; 2019 Jan; 35(1):108-112. PubMed ID: 29923637
[TBL] [Abstract][Full Text] [Related]
25. Office-Based Opioid Treatment with Buprenorphine (OBOT-B): Statewide Implementation of the Massachusetts Collaborative Care Model in Community Health Centers.
LaBelle CT; Han SC; Bergeron A; Samet JH
J Subst Abuse Treat; 2016 Jan; 60():6-13. PubMed ID: 26233698
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.
Isetts BJ; Buffington DE; Carter BL; Smith M; Polgreen LA; James PA
Pharmacotherapy; 2016 Apr; 36(4):374-84. PubMed ID: 26893135
[TBL] [Abstract][Full Text] [Related]
27. Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic.
Cochran G; Bruneau J; Cox N; Gordon AJ
Subst Abus; 2020; 41(3):269-274. PubMed ID: 32697171
[TBL] [Abstract][Full Text] [Related]
28. Feasibility of collaborative care treatment of opioid use disorders with buprenorphine during pregnancy.
Mittal L; Suzuki J
Subst Abus; 2017; 38(3):261-264. PubMed ID: 26672650
[TBL] [Abstract][Full Text] [Related]
29. Research Priorities for Expansion of Opioid Use Disorder Treatment in the Community Pharmacy.
Jarrett JB; Bratberg J; Burns AL; Cochran G; DiPaula BA; Legreid Dopp A; Elmes A; Green TC; Hill LG; Homsted F; Hsia SL; Matthews ML; Ghitza UE; Wu LT; Bart G
Subst Abus; 2023 Oct; 44(4):264-276. PubMed ID: 37902032
[TBL] [Abstract][Full Text] [Related]
30. Physicians' experiences with buprenorphine: A qualitative study of motivations for becoming X waivered and barriers to and facilitators of prescribing the medication for opioid use disorder.
McCollum CG; Eaton E; Creger T; Lee A; Gagnon K; Li L
Drug Alcohol Depend; 2023 Mar; 244():109777. PubMed ID: 36680808
[TBL] [Abstract][Full Text] [Related]
31. Perspectives on and experiences of emergency department-initiated buprenorphine among clinical pharmacists: A multi-site qualitative study.
Justen M; Edelman EJ; Chawarski M; Coupet E; Cowan E; Lyons M; Owens P; Martel S; Richardson L; Rothman R; Whiteside L; O'Connor PG; Zahn E; D'Onofrio G; Fiellin DA; Hawk KF
J Subst Use Addict Treat; 2023 Dec; 155():209058. PubMed ID: 37149149
[TBL] [Abstract][Full Text] [Related]
32. Interest in prescribing buprenorphine among resident and attending physicians at an urban teaching clinic.
James JR; Gordon LM; Klein JW; Merrill JO; Tsui JI
Subst Abus; 2019; 40(1):11-13. PubMed ID: 29578857
[No Abstract] [Full Text] [Related]
33. Community Pharmacists' Knowledge and Perceptions of Buprenorphine for Patients with Opioid Use Disorder.
Tutag Lehr V; Nolan C
J Addict Med; 2023 Jul-Aug 01; 17(4):e224-e231. PubMed ID: 37579094
[TBL] [Abstract][Full Text] [Related]
34. User centered clinical decision support to implement initiation of buprenorphine for opioid use disorder in the emergency department: EMBED pragmatic cluster randomized controlled trial.
Melnick ER; Nath B; Dziura JD; Casey MF; Jeffery MM; Paek H; Soares WE; Hoppe JA; Rajeevan H; Li F; Skains RM; Walter LA; Patel MD; Chari SV; Platts-Mills TF; Hess EP; D'Onofrio G
BMJ; 2022 Jun; 377():e069271. PubMed ID: 35760423
[TBL] [Abstract][Full Text] [Related]
35. Beyond state scope of practice laws for advanced practitioners: Additional supervision requirements for buprenorphine prescribing.
Andraka-Christou B; Gordon AJ; Spetz J; Totaram R; Golan M; Randall-Kosich O; Harrison J; Calder S; Kertesz SG; Stein BD
J Subst Abuse Treat; 2022 Jul; 138():108715. PubMed ID: 35067400
[TBL] [Abstract][Full Text] [Related]
36. Pharmacists' attitudes toward dispensing naloxone and medications for opioid use disorder: A scoping review of the literature.
Muzyk A; Smothers ZPW; Collins K; MacEachern M; Wu LT
Subst Abus; 2019; 40(4):476-483. PubMed ID: 31418645
[No Abstract] [Full Text] [Related]
37. Prevalence, Distribution, and Characteristics Associated With Possession of Buprenorphine Waivers Among Infectious Diseases Physicians in the United States.
Fujita AW; Loughry N; Moore DE; Carter AE; Hussen SA; Cooper H; Colasanti JA; Sheth AN
Clin Infect Dis; 2023 Apr; 76(7):1197-1204. PubMed ID: 36419250
[TBL] [Abstract][Full Text] [Related]
38. Characteristics and prescribing practices of clinicians recently waivered to prescribe buprenorphine for the treatment of opioid use disorder.
Jones CM; McCance-Katz EF
Addiction; 2019 Mar; 114(3):471-482. PubMed ID: 30194876
[TBL] [Abstract][Full Text] [Related]
39. The Supply of Physicians Waivered to Prescribe Buprenorphine for Opioid Use Disorders in the United States: A State-Level Analysis.
Knudsen HK
J Stud Alcohol Drugs; 2015 Jul; 76(4):644-54. PubMed ID: 26098042
[TBL] [Abstract][Full Text] [Related]
40. Prescribing Practices of Rural Physicians Waivered to Prescribe Buprenorphine.
Andrilla CHA; Coulthard C; Patterson DG
Am J Prev Med; 2018 Jun; 54(6 Suppl 3):S208-S214. PubMed ID: 29779544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
